chr3-63990469-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001377405.1(ATXN7):c.1560+95G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0827 in 1,459,308 control chromosomes in the GnomAD database, including 5,535 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.069 ( 466 hom., cov: 32)
Exomes 𝑓: 0.084 ( 5069 hom. )
Consequence
ATXN7
NM_001377405.1 intron
NM_001377405.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.25
Genes affected
ATXN7 (HGNC:10560): (ataxin 7) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.129 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN7 | NM_001377405.1 | c.1560+95G>A | intron_variant | Intron 10 of 12 | ENST00000674280.1 | NP_001364334.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0693 AC: 10546AN: 152184Hom.: 465 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10546
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0843 AC: 110129AN: 1307006Hom.: 5069 Cov.: 20 AF XY: 0.0842 AC XY: 54786AN XY: 650832 show subpopulations
GnomAD4 exome
AF:
AC:
110129
AN:
1307006
Hom.:
Cov.:
20
AF XY:
AC XY:
54786
AN XY:
650832
Gnomad4 AFR exome
AF:
AC:
659
AN:
30390
Gnomad4 AMR exome
AF:
AC:
7148
AN:
40822
Gnomad4 ASJ exome
AF:
AC:
2258
AN:
22678
Gnomad4 EAS exome
AF:
AC:
5076
AN:
38250
Gnomad4 SAS exome
AF:
AC:
7204
AN:
76394
Gnomad4 FIN exome
AF:
AC:
2408
AN:
48812
Gnomad4 NFE exome
AF:
AC:
80328
AN:
990364
Gnomad4 Remaining exome
AF:
AC:
4663
AN:
55034
Heterozygous variant carriers
0
5252
10505
15757
21010
26262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
3018
6036
9054
12072
15090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0693 AC: 10551AN: 152302Hom.: 466 Cov.: 32 AF XY: 0.0688 AC XY: 5121AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
10551
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
5121
AN XY:
74466
Gnomad4 AFR
AF:
AC:
0.023711
AN:
0.023711
Gnomad4 AMR
AF:
AC:
0.120606
AN:
0.120606
Gnomad4 ASJ
AF:
AC:
0.100518
AN:
0.100518
Gnomad4 EAS
AF:
AC:
0.136875
AN:
0.136875
Gnomad4 SAS
AF:
AC:
0.0946058
AN:
0.0946058
Gnomad4 FIN
AF:
AC:
0.0485117
AN:
0.0485117
Gnomad4 NFE
AF:
AC:
0.0804128
AN:
0.0804128
Gnomad4 OTH
AF:
AC:
0.0855388
AN:
0.0855388
Heterozygous variant carriers
0
494
988
1482
1976
2470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
308
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at